Endocan expression is increased in the placenta from obese women with gestational diabetes mellitus

Placenta

Volumn 48, Issue , 2016, Pages 38-48

  Murthi, Padma ^a,b   Sarkis, Ramona ^b   Lim, Ratana ^b,c   Nguyen Ngo, Caitlyn ^b,c   Pratt, Anita ^b   Liong, Stella ^b,c   Lappas, Martha ^b,c  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c MERCY HOSPITAL FOR WOMEN   (Australia)

Author keywords

Endocan; GDM; Inflammation; Placenta

Indexed keywords

ENDOCAN; INSULIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEOGLYCAN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; CYTOKINE; ESM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; BODY MASS; CARBOHYDRATE ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DIABETIC DIET; EMBRYO; FEMALE; GENE EXPRESSION; GENE SILENCING; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; LEAN BODY WEIGHT; LOSS OF FUNCTION MUTATION; MATERNAL OBESITY; PLACENTA; PREGNANCY DIABETES MELLITUS; PREGNANT WOMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; TROPHOBLAST; UMBILICAL VEIN ENDOTHELIAL CELL; GENETICS; METABOLISM; OBESITY; PREGNANCY;

ADULT; CYTOKINES; DIABETES, GESTATIONAL; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NEOPLASM PROTEINS; OBESITY; PLACENTA; PREGNANCY; PROTEOGLYCANS; RNA, SMALL INTERFERING;

EID: 84991585182     PISSN: 01434004     EISSN: 15323102     Source Type: Journal    
DOI: 10.1016/j.placenta.2016.10.003     Document Type: Article

References (56)

1. [1] Hardingham, T.E., Fosang, A.J., Proteoglycans - many forms and many functions. Faseb J. 6:3 (1992), 861–870.
2. [2] Delehedde, M., Devenyns, L., Maurage, C.-A., Vivès, R.R., Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int. J. Cell Biol., 2013, 2013, 705027, 10.1155/2013/705027.
3. [3] Bechard, D., Gentina, T., Delehedde, M., Scherpereel, A., Lyon, M., Aumercier, M., Vazeux, R., Richet, C., Degand, P., Jude, B., Janin, A., Fernig, D.G., Tonnel, A.B., Lassalle, P., Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. 2001.
4. [4] Lassalle, P., Molet, S., Janin, A., Van der Heyden, J., Tavernier, J., Fiers, W., Devos, R., Tonnel, A.-B., ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines. J. Biol. Chem. 271:34 (1996), 20458–20464.
5. [5] Balta, S., Mikhailidis, D.P., Demirkol, S., Ozturk, C., Celik, T., Iyisoy, A., Endocan: a novel inflammatory indicator in cardiovascular disease?. Atherosclerosis 243:1 (2015), 339–343.
6. [6] Kali, A., Shetty, K.S.R., Endocan: a novel circulating proteoglycan. Indian J. Pharmacol. 46:6 (2014), 579–583.
7. [7] Kim, J.H., Park, M.Y., Kim, C.N., Kim, K.H., Kang, H.B., Kim, K.D., Kim, J.W., Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1alpha in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features. Oncol. Rep. 28:5 (2012), 1701–1708.
8. [8] Kim, K.S., Lee, Y.A., Ji, H.I., Song, R., Kim, J.Y., Lee, S.H., Hong, S.J., Yoo, M.C., Yang, H.I., Increased expression of endocan in arthritic synovial tissues: effects of adiponectin on the expression of endocan in fibroblast-like synoviocytes. Mol. Med. Rep. 11:4 (2015), 2695–2702.
9. [9] Lee, W., Ku, S.K., Kim, S.W., Bae, J.S., Endocan elicits severe vascular inflammatory responses in vitro and in vivo. J. Cell. physiology 229:5 (2014), 620–630.
10. [10] Aparci, M., Isilak, Z., Uz, O., Yalcin, M., Kucuk, U., Endocan and endothelial dysfunction. Angiology 66:5 (2015), 488–489.
11. [11] Abid, M.R., Yi, X., Yano, K., Shih, S.-C., Aird, W.C., Vascular endocan is preferentially expressed in tumor endothelium. Microvasc. Res. 72:3 (2006), 136–145.
12. [12] Grigoriu, B.D., Depontieu, F., Scherpereel, A., Gourcerol, D., Devos, P., Ouatas, T., Lafitte, J.-J., Copin, M.-C., Tonnel, A.-B., Lassalle, P., Thoracic Oncology, G., Endocan expression and relationship with survival in human non-small cell lung cancer. Clin. Cancer Res. 12:15 (2006), 4575–4582.
13. [13] Sarrazin, S., Adam, E., Lyon, M., Depontieu, F., Motte, V., Landolfi, C., Lortat-Jacob, H., Bechard, D., Lassalle, P., Delehedde, M., Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochimica Biophysica Acta-Reviews Cancer 1765:1 (2006), 25–37.
14. [14] Scherpereel, A., Gentina, T., Grigoriu, B., Senechal, S., Janin, A., Tsicopoulos, A., Plenat, F., Bechard, D., Tonnel, A.B., Lassalle, P., Overexpression of endocan induces tumor formation. Cancer Res. 63:18 (2003), 6084–6089.
15. [15] Janke, J., Engeli, S., Gorzelniak, K., Feldpausch, M., Heintze, U., Böhnke, J., Wellner, M., Herse, F., Lassalle, P., Luft, F.C., Sharma, A.M., Adipose tissue and circulating endothelial cell specific molecule-1 in human obesity. Hormone Metabolic Res. = Hormon- Und Stoffwechselforschung = Hormones Métabolisme 38:1 (2006), 28–33.
16. [16] Cox, L.A.E., van Eijk, L.T., Ramakers, B.P.C., Dorresteijn, M.J., Gerretsen, J., Kox, M., Pickkers, P., Inflammation-induced increases in plasma endocan levels are associated with endothelial dysfunction in humans in vivo. Shock (Augusta, Ga) 43:4 (2015), 322–326.
17. [17] Paulus, P., Jennewein, C., Zacharowski, K., Biomarkers of endothelial dysfunction: can they help us deciphering systemic inflammation and sepsis?. Biomarkers 16 (2011), S11–S21.
18. [18] Chang, X., Bian, Y., Wu, Y., Huang, Y., Wang, K., Duan, T., Endocan of the maternal placenta tissue is increased in pre-eclampsia. Int. J. Clin. Exp. pathology 8:11 (2015), 14733–14740.
19. [19] Aye, I.L., Lager, S., Ramirez, V.I., Gaccioli, F., Dudley, D.J., Jansson, T., Powell, T.L., Increasing maternal body mass index is associated with systemic inflammation in the mother and the activation of distinct placental inflammatory pathways. Biol. Reprod., 90(6), 2014 Jun, 129, 10.1095/biolreprod.113.116186.
20. [20] Challier, J.C., Basu, S., Bintein, T., Minium, J., Hotmire, K., Catalano, P.M., Hauguel-de Mouzon, S., Obesity in pregnancy stimulates macrophage accumulation and inflammation in the placenta. Placenta 29:3 (2008), 274–281.
21. [21] Roberts, K.A., Riley, S.C., Reynolds, R.M., Barr, S., Evans, M., Statham, A., Hor, K., Jabbour, H.N., Norman, J.E., Denison, F.C., Placental structure and inflammation in pregnancies associated with obesity. Placenta 32:3 (2011), 247–254.
22. [22] Aye, I.L., Jansson, T., Powell, T.L., Interleukin-1beta inhibits insulin signaling and prevents insulin-stimulated system A amino acid transport in primary human trophoblasts. Mol. Cell. Endocrinol. 381:1–2 (2013), 46–55.
23. [23] Saben, J., Zhong, Y., Gomez-Acevedo, H., Thakali, K.M., Borengasser, S.J., Andres, A., Shankar, K., Early growth response protein-1 mediates lipotoxicity-associated placental inflammation: role in maternal obesity. Am. J. physiology Endocrinol. metabolism 305:1 (2013), E1–E14.
24. [24] Retnakaran, R., Hanley, A.J., Raif, N., Connelly, P.W., Sermer, M., Zinman, B., C-reactive protein and gestational diabetes: the central role of maternal obesity. J. Clin. Endocrinol. metabolism 88:8 (2003), 3507–3512.
25. [25] Radaelli, T., Varastehpour, A., Catalano, P., Hauguel-de Mouzon, S., Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 52:12 (2003), 2951–2958.
26. [26] Kuzmicki, M., Telejko, B., Szamatowicz, J., Zonenberg, A., Nikolajuk, A., Kretowski, A., Gorska, M., High resistin and interleukin-6 levels are associated with gestational diabetes mellitus. Gynecological endocrinology. official J. Int. Soc. Gynecol. Endocrinol. 25:4 (2009), 258–263.
27. [27] Lappas, M., Activation of inflammasomes in adipose tissue of women with gestational diabetes. Mol. Cell. Endocrinol. 382:1 (2014), 74–83.
28. [28] Lappas, M., The NR4A receptors Nurr1 and Nur77 are increased in human placenta from women with gestational diabetes. Placenta 35:11 (2014), 866–875.
29. [29] Lappas, M., Permezel, M., Rice, G.E., Release of proinflammatory cytokines and 8-isoprostane from placenta, adipose tissue, and skeletal muscle from normal pregnant women and women with gestational diabetes mellitus. J. Clin. Endocr. Metab. 89:11 (2004), 5627–5633.
30. [30] Basu, S., Haghiac, M., Surace, P., Challier, J.C., Guerre-Millo, M., Singh, K., Waters, T., Minium, J., Presley, L., Catalano, P.M., Hauguel-de Mouzon, S., Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity 19:3 (2011), 476–482.
31. [31] Crampton, S.P., Davis, J., Hughes, C.C., Isolation of human umbilical vein endothelial cells (HUVEC). J. Vis. Exp., 183(3), 2007, 10.3791/183 Epub 2007 Apr 28.
32. [32] Lim, R., Barker, G., Riley, C., Lappas, M., Apelin is decreased with human preterm and term labor and regulates prolabor mediators in human primary amnion cells. Reprod. Sci. 20:8 (2013 Aug), 957–967, 10.1177/1933719112472741.
33. [33] Borg, A.J., Yong, H.E., Lappas, M., Degrelle, S.A., Keogh, R.J., Da Silva-Costa, F., Fournier, T., Abumaree, M., Keelan, J.A., Kalionis, B., Murthi, P., Decreased STAT3 in human idiopathic fetal growth restriction contributes to trophoblast dysfunction. Reproduction 149:5 (2015), 523–532.
34. [34] Chui, A., Murthi, P., Brennecke, S.P., Ignjatovic, V., Monagle, P.T., Said, J.M., The expression of placental proteoglycans in pre-eclampsia. Gynecol. Obstetric Investigation 73:4 (2012), 277–284.
35. [35] Lanir N, Aharon A and Brenner B. Procoagulant and Anticoagulant Mechanisms in Human Placenta. p. 175–184.
36. [36] Yang, W.-C., Su, T.-H., Yang, Y.-C., Chang, S.-C., Chen, C.-Y., Chen, C.-P., Altered perlecan expression in placental development and gestational diabetes mellitus. Placenta 26:10 (2005), 780–788.
37. [37] Lysiak, J., Hunt, J., Pringle, G., Lala, P., Localization of transforming growth factor β and its natural inhibitor decorin in the human placenta and decidua throughout gestation. Placenta 16:3 (1995), 221–231.
38. [38] Li, D., Clark, C.C., Myers, J.C., Basement membrane zone type XV collagen is a disulfide-bonded chondroitin sulfate proteoglycan in human tissues and cultured cells. J. Biol. Chem. 275:29 (2000), 22339–22347.
39. [39] Leushner, J.R., Tevaarwerk, G.J., Clarson, C.L., Harding, P.G., Chance, G.W., Haust, M.D., Analysis of the collagens of diabetic placental villi. Cell. Mol. Biol. 32:1 (1986), 27–35.
40. [40] Rukosuev, V., Immunofluorescent localization of collagen types I, III, IV, V, fibronectin, laminin, entactin, and heparan sulphate proteoglycan in human immature placenta. Experientia 48:3 (1992), 285–287.
41. [41] Murthi, P., Faisal, F.A., Rajaraman, G., Stevenson, J., Ignjatovic, V., Monagle, P.T., Brennecke, S.P., Said, J.M., Placental biglycan expression is decreased in human idiopathic fetal growth restriction. Placenta 31 (2010), 712–717.
42. [42] Swan, B., Murthi, P., Rajaraman, G., Pathirage, N., Said, J., Ignjatovic, V., Monagle, P., Brennecke, S., Decorin expression is decreased in human idiopathic fetal growth restriction. Reproduction, Fertil. Dev. 22:6 (2010), 949–955.
43. [43] Chen, C.P., Chang, S.C., Vivian Yang, W.C., High glucose alters proteoglycan expression and the glycosaminoglycan composition in placentas of women with gestational diabetes mellitus and in cultured trophoblasts. Placenta 28:2–3 (2007), 97–106.
44. [44] Desoye, G., Hauguel-de Mouzon, S., The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes care 30:Suppl 2 (2007), S120–S126.
45. [45] Basu, S., Haghiac, M., Surace, P., Challier, J.C., Guerre-Millo, M., Singh, K., Waters, T., Minium, J., Presley, L., Catalano, P.M., Hauguel-de Mouzon, S., Pregravid Obesity Associates with Increased Maternal Endotoxemia and Metabolic Inflammation. 2010, Obesity, Silver Spring.
46. [46] Klein, K., Satler, M., Elhenicky, M., Brix, J., Krzyzanowska, K., Schernthaner, G., Husslein, P.W., Schernthaner, G.-H., Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat. Diagn. 28:9 (2008), 845–851.
47. [47] Kirwan, J.P., Hauguel-De Mouzon, S., Lepercq, J., Challier, J.C., Huston-Presley, L., Friedman, J.E., Kalhan, S.C., Catalano, P.M., TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 51:7 (2002), 2207–2213.
48. [48] Klein, K., Satler, M., Elhenicky, M., Brix, J., Krzyzanowska, K., Schernthaner, G., Husslein, P.W., Schernthaner, G.H., Circulating levels of MCP-1 are increased in women with gestational diabetes. Prenat. Diagn 28:9 (2008), 845–851.
49. [49] Vitoratos, N., Valsamakis, G., Mastorakos, G., Boutsiadis, A., Salakos, N., Kouskouni, E., Creatsas, G., Pre- and early post-partum adiponectin and interleukin-1beta levels in women with and without gestational diabetes. Hormones 7:3 (2008), 230–236.
50. [50] Ategbo, J.M., Grissa, O., Yessoufou, A., Hichami, A., Dramane, K.L., Moutairou, K., Miled, A., Grissa, A., Jerbi, M., Tabka, Z., Khan, N.A., Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J. Clin. Endocrinol. metabolism 91:10 (2006), 4137–4143.
51. [51] Coughlan, M.T., Oliva, K., Georgiou, H.M., Permezel, J.M., Rice, G.E., Glucose-induced release of tumour necrosis factor-alpha from human placental and adipose tissues in gestational diabetes mellitus. Diabetic medicine. a J. Br. Diabet. Assoc. 18:11 (2001), 921–927.
52. [52] Wellner, M., Herse, F., Janke, J., Gorzelniak, K., Engeli, S., Bechart, D., Lasalle, P., Luft, F.C., Sharma, A.M., Endothelial cell specific molecule-1–a newly identified protein in adipocytes. Horm. Metab. Res. 35:4 (2003), 217–221.
53. [53] Di Fulvio, P., Pandolfi, A., Formoso, G., Di Silvestre, S., Di Tomo, P., Giardinelli, A., De Marco, A., Di Pietro, N., Taraborrelli, M., Sancilio, S., Di Pietro, R., Piantelli, M., Consoli, A., Features of endothelial dysfunction in umbilical cord vessels of women with gestational diabetes. Nutrition, metabolism, and cardiovascular diseases. NMCD 24:12 (2014), 1337–1345.
54. [54] Arman, Y., Akpinar, T.S., Kose, M., Emet, S., Yuruyen, G., Akarsu, M., Ozcan, M., Yegit, O., Cakmak, R., Altun, O., Aydin, S., Alibeyoğlu, A., Ugurlu, B., Akcan, T., Tukek, T., Effect of glycemic regulation on endocan levels in patients with diabetes: a preliminary study. Angiology 67:3 (2016 Mar), 239–244, 10.1177/0003319715585664 Epub 2015 May 12.
55. [55] Adekola, H., Romero, R., Chaemsaithong, P., Korzeniewski, S.J., Dong, Z., Yeo, L., Hassan, S.S., Chaiworapongsa, T., Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J. Of Maternal-Fetal Neonatal Med. Official J. Of Eur. Assoc. Of Perinat. Med., 2014, 1–12, The Federation Of Asia And Oceania Perinatal Societies, The International Society Of Perinatal Obstetricians.
56. [56] Pawlak, K., Mysliwiec, M., Pawlak, D., Endocan — the new endothelial activation marker independently associated with soluble endothelial adhesion molecules in uraemic patients with cardiovascular disease. Clin. Biochem. 48:6 (2015), 425–430.